Medicare Enrolled

Dr. Eric Chin, M.D.

Ophthalmology · Redlands, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
1895 ORANGE TREE LN STE 204, Redlands, CA 92374
9097963003
In practice since 2009 (16 years)
NPI: 1043442809 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chin

Dr. Eric Chin is an ophthalmology specialist in Redlands, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Chin performed 15,778 Medicare services across 3,401 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chin received a total of $12,235 from 29 pharmaceutical and/or device companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 7% volume in CA $12,235 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,778
Medicare services
Top 7% in CA for ophthalmology
3,401
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~986 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
6,480 $29 $57
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,712 $33 $88
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,302 $103 $399
Injection, ranibizumab, 0.1 mg 1,123 $181 $420
Aflibercept eye injection (Eylea) 1,112 $685 $1,120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,035 $98 $237
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
535 $20 $63
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
503 $30 $99
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
399 $210 $710
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
375 $120 $507
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
274 $71 $250
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
242 $57 $222
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
142 $113 $282
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
119 $39 $173
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
115 $74 $153
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
111 $114 $304
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
80 $12 $55
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
67 $1,661 $3,203
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
31 $271 $1,472
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
21 $433 $1,212
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,235
Total received (2018-2024)
Avg $1,748/year across 7 years
Top 13% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
136
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,672 (46.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,963 (32.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,599 (21.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,537
2023
$1,243
2022
$3,097
2021
$2,360
2020
$190
2019
$1,176
2018
$1,631

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,774
Genentech USA, Inc.
$212
Sandoz Inc.
$131
Apellis Pharmaceuticals, Inc.
$99
Astellas Pharma US Inc
$87
Regeneron Healthcare Solutions, Inc.
$85
Biogen, Inc.
$44
ANI Pharmaceuticals, Inc.
$36
Coherus Biosciences Inc.
$30
C. R. Bard, Inc. & Subsidiaries
$20
Alimera Sciences, Inc.
$19
Top 3 companies account for 83.4% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$2,562
Allergan, Inc.
$1,869
ABBVIE INC.
$1,820
Genentech, Inc.
$1,812
Genentech USA, Inc.
$587
Novartis Pharmaceuticals Corporation
$567
Mallinckrodt Hospital Products Inc.
$482
Regeneron Healthcare Solutions, Inc.
$472
Vertex Pharmaceuticals Incorporated
$350
Apellis Pharmaceuticals, Inc.
$259
Allergan Inc.
$178
Dutch Ophthalmic, USA
$172
Coherus Biosciences Inc.
$135
Sandoz Inc.
$131
Dompe US, Inc.
$122
Astellas Pharma US Inc
$110
Horizon Therapeutics plc
$109
AbbVie Inc.
$91
OPTOS, INC.
$87
Biogen, Inc.
$84
Carl Zeiss Meditec, Inc.
$58
Vyera Pharmaceuticals, LLC
$36
ANI Pharmaceuticals, Inc.
$36
Bausch & Lomb Americas Inc.
$23
C. R. Bard, Inc. & Subsidiaries
$20
Carl Zeiss Meditec AG
$19
EyePoint Pharmaceuticals US, Inc.
$18
Alcon Vision LLC
$15
VYERA PHARMACEUTICALS, LLC
$15
Top 3 companies account for 51.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROLUCIZUMAB · BYOOVIZ · Cimerli · Clareon · DEXYCU · Daraprim · Daraprim Tablet 25mg · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · Izervay · Lucentis · Non-Covered Product · None Specified · OPMI Lumera · OXERVATE · OZURDEX · P200DTx · PURIFIED CORTROPHIN GEL · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · Vabysmo · XIPERE · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (46%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Redlands?
Compare ophthalmologists in the Redlands area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
111
Per 100K population
5.1
County median income
$82,184
Nearest hospital
REDLANDS COMMUNITY HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chin is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with mixed engagement industry engagement in the top 13% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chin experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Chin performed 6,480 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chin receive payments from pharmaceutical companies?
Yes. Dr. Chin received a total of $12,235 from 29 companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chin's costs compare to other ophthalmologists in Redlands?
Dr. Chin's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →